Related Experiment Video
Updated: Aug 26, 2025

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
Published on: October 20, 2023
Aortic Stenosis: New Insights in Diagnosis, Treatment, and Prevention
Insights
Aortic stenosis (AS) is a growing concern in the elderly population. Early detection and new treatments like transcatheter aortic valve replacement (TAVR) are crucial for managing this complex heart disease.
Area of Science:
- Cardiology
- Geriatric Medicine
- Valvular Heart Disease
Background:
- Aortic stenosis (AS) is a prevalent valvular heart disease, with increasing global incidence due to aging populations.
- AS in the elderly often presents with complex comorbidities beyond left ventricular outflow obstruction.
- Identifying high-risk patients and enabling earlier AS detection is critical for timely intervention.
Purpose of the Study:
- To review recent advancements in understanding and managing aortic stenosis.
- To discuss the evolving role of transcatheter aortic valve replacement (TAVR) in AS management.
- To explore emerging medical therapies for preventing or slowing AS progression.
Main Methods:
- Comprehensive literature review of recent findings in aortic stenosis.
- Analysis of current evidence regarding transcatheter aortic valve replacement (TAVR) efficacy and safety.
- Examination of ongoing randomized controlled trials for novel medical therapies.
Main Results:
- Transcatheter aortic valve replacement (TAVR) has demonstrated efficacy and safety in severe AS.
- Growing interest exists in applying TAVR to patients with less than severe AS.
- Medical therapies to mitigate AS progression are under active investigation.
Conclusions:
- Effective management of aortic stenosis requires addressing its complexity and comorbidities in the elderly.
- Earlier detection and risk stratification are paramount for optimizing patient outcomes.
- Future strategies will likely involve a combination of TAVR and novel medical therapies to manage AS progression.
Abstract:
Aortic stenosis (AS) is one of the most common valvular heart diseases and the number of patients with AS is expected to increase globally as the older population is growing fast. Since the majority of patients are elderly, AS is no longer a simple valvular heart disease of left ventricular outflow obstruction but is accompanied by other cardiac and comorbid conditions. Because of the significant variations of the disease, identifying patients at high risk and even earlier detection of patients with AS before developing symptomatic severe AS is becoming increasingly important. With the proven of efficacy and safety of transcatheter aortic valve replacement (TAVR) in the severe AS population, there is a growing interest in applying TAVR in those with less than severe AS. A medical therapy to reduce or prevent the progression in AS is actively investigated by several randomized control trials. In this review, we will summarize the most recent findings in AS and discuss potential future management strategies of patients with AS.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Aortic Regurgitation I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis III: Management
Aneurysm III: Interprofessional Care

